Does Weed Cause Schizophrenia? What the Research Says (2026)

By James Buddsey · Updated October 16, 2026

Weed does not cause schizophrenia in most users, but strong evidence shows that frequent cannabis use, especially daily use of high-THC products starting in the teens, raises the risk of psychosis and schizophrenia. The National Academies rated the link as substantial, and heavy users have roughly two to four times the risk of non-users. Whether cannabis directly causes the illness is still debated, but most researchers now think it plays a causal role for some people.

This page started as a short summary of two older studies, one Dutch and one from a British government advisory body, that were reported as showing cannabis does not cause schizophrenia. Those studies were real, but the headline oversimplified them, and two decades of research since have sharpened the picture considerably. This guide covers what the evidence says as of October 2026, who is most at risk and what to do with that information.

Cannabis and Schizophrenia: Evidence at a Glance

What the Older Studies Actually Found

The Dutch study. The most cited Dutch research from that period is the NEMESIS study, published in the American Journal of Epidemiology in 2002. It followed 4,045 adults without psychosis for three years. Cannabis use at the start predicted psychotic symptoms later, including severe symptoms, and the authors estimated that more than half of the psychosis diagnoses could be attributed to cannabis. The effect was far stronger in people who already had a psychotic disorder. So the Dutch finding was not that cannabis is harmless. It was that cannabis raises risk for the general population and is especially harmful for people who are already vulnerable, which is why the researchers advised people with a family history to avoid it.

The British advisory body. The UK’s Advisory Council on the Misuse of Drugs recommended in 2002 that cannabis move from Class B to the less serious Class C, which happened in 2004. In its later reviews the council judged the added mental health risk for most users to be small and advised keeping cannabis in Class C. The government moved it back to Class B in 2009 against that advice, citing concern about stronger cannabis and mental health. The council’s view was a judgment about legal classification, not a finding that cannabis has no effect on psychosis.

What Current Research Shows

The link is consistent and dose-dependent

A 2007 Lancet systematic review of 35 long-term population studies found that people who had ever used cannabis had about a 41% higher risk of a psychotic outcome, and the most frequent users had about twice the risk. A 2016 meta-analysis found the heaviest users had nearly four times the odds of schizophrenia and related outcomes compared with non-users, with risk rising step by step with use. In 2017 the National Academies found substantial evidence of a link between cannabis use and schizophrenia or other psychoses, highest among the most frequent users.

Potency matters

The European EU-GEI study compared 901 people with a first episode of psychosis to 1,237 people from the same communities in 11 cities. Daily use raised the odds of psychotic disorder about threefold, and daily use of cannabis with 10% THC or more raised them nearly fivefold. Assuming cause and effect, the authors estimated that removing high-potency cannabis would prevent about 30% of new psychosis cases in London and 50% in Amsterdam. Most flower sold in Washington and Oregon stores today is labeled well above that 10% threshold, and concentrates far above it.

Young men are most at risk

A Danish study of nearly 6.9 million people followed from 1972 to 2021 found that cannabis use disorder was linked to about double the risk of schizophrenia overall. Among 16- to 20-year-old men, the risk was nearly four times higher. The authors estimated that, if the link is causal, about one in five schizophrenia cases among young men could be prevented by preventing cannabis use disorder, and that share has risen over time as cannabis has become stronger.

Cannabis-induced psychosis is a warning sign

A temporary psychotic episode triggered by cannabis is not always temporary. In a Danish register study of 6,788 people diagnosed with substance-induced psychosis, 47.4% of those whose episode was triggered by cannabis later developed schizophrenia or bipolar disorder, the highest rate of any substance. Half of the conversions to schizophrenia happened within about three years.

Does Weed Cause Schizophrenia, or Do People at Risk Use More Weed?

Both may be true. Observational studies cannot fully rule out reverse causation, where early symptoms lead people to use cannabis, or shared factors such as genes, trauma and other drug use.

Mendelian randomization studies try to get around that by using genetic variants as a natural experiment. A 2017 study of this kind found some evidence that starting cannabis increases schizophrenia risk, though the estimated effect was small, and stronger evidence that genetic risk for schizophrenia makes people more likely to try cannabis. The 2007 Lancet review concluded that the evidence was consistent with cannabis raising psychosis risk beyond confounding and that young people should be warned.

The fair summary: cannabis is neither necessary nor sufficient to cause schizophrenia. Most heavy users never develop it, and many people with schizophrenia never used cannabis. But frequent use, especially of strong products in adolescence, appears to tip some vulnerable people into illness earlier or more often than would otherwise happen.

Who Is Most at Risk?

• People with a parent or sibling who has schizophrenia, bipolar disorder or psychosis
• Teenagers and young adults, especially young men, while the brain is still developing
• Daily users and people with cannabis use disorder
• Users of high-THC flower, vapes and concentrates
• Anyone who has had a psychotic episode, paranoia or hallucinations while high

Can CBD Help Schizophrenia?

CBD acts differently from THC, and early research suggests it may have antipsychotic properties. In a 2018 trial of 88 patients already on antipsychotic medication, adding 1,000 mg a day of CBD for six weeks modestly reduced positive symptoms such as hallucinations compared with placebo and was well tolerated. That was a small, short trial run with GW Pharmaceuticals, a maker of CBD medicine, and CBD is not approved for schizophrenia. Over-the-counter CBD products are far lower in dose and may contain THC. See our CBD evidence guide.

Risks and Side Effects

• Acute psychotic symptoms: high doses of THC can cause paranoia, hallucinations and panic, even in people with no history of mental illness.
• Worse course of existing illness: in the Dutch NEMESIS study, the effect of cannabis was much stronger in people who already had a psychotic disorder.
• Cannabis use disorder: about 3 in 10 users meet criteria, according to the CDC, and the disorder is strongly linked to schizophrenia risk.
• Depression and suicidal thoughts: also linked to heavy use; see our cannabis and depression guide.
• Teen brain development: see does marijuana cause brain damage and marijuana and IQ.

Talk to Your Doctor

If you have a family history of schizophrenia or bipolar disorder, the safest choice is to avoid cannabis, or at least avoid high-THC products and daily use. If you have ever had paranoia, hallucinations or confused thinking while high, take it seriously, stop using and tell a doctor. Early treatment of psychosis improves long-term outcomes. If you have schizophrenia and use cannabis, talk openly with your psychiatrist so your treatment plan accounts for it. In a mental health crisis in the U.S., call or text 988.

Weed and Schizophrenia FAQ

More studies in our cannabis research section.

For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.